Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
thymosin alpha-1 immune enhancement potentially conflicting with immunosuppressive therapies
Key benefits include enhanced joint and tendon regeneration, faster recovery from injuries, improved digestive health support, muscle tissue recovery, and overall body regeneration support
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity [3] , though human clinical data remain limited to early-phase safety trials and small case reports [4] [5]
Severe allergic reactions, such as itching or difficulty breathing, are rare but possible
US$ 21.64
US$ 23.89
US$ 21.08
US$ 22.62
